There are an estimated 200,000 severe ADRs in Canada each year, though it is estimated that 95% of ADRs are not reported. They cost the Canadian healthcare system between $13.7 and $17.7 billion each year and kill up to 22,000 Canadians each year. Over 5,000 of these are Canadian children. ADR Canada is working to prevent this.

About

About Adverse Drug Reaction Canada  ADR Canada is a national, non-partisan, not-for-profit organization that advocates for the prevention of adverse drug reactions. It brings together patients, families, policy-makers, scientists, researchers, health care providers and academics to advocate, develop policy solutions and advance research to prevent adverse drug reactions across Canada. Mission  To improve quality of… Continue reading About

Policies

ADR Canada advocates for three policies which will lead Canada on the path to preventing adverse drug reactions: 1. Establishing a national mandatory database to record and monitor all adverse drug reactions. 2. Establishing publicly funded genetic screening to identify gene variants in individuals that can lead to adverse drug reactions. 3. Establishing a centralized… Continue reading Policies

Recent ADR News

DNA on drugs: How genetic tests could make prescriptions more precise, Carolyn Abraham, March 16, 2018, The Globe and Mail Jane Philpott moves on. Health Canada’s drug problems remain, Anne Kingston, August 28, 2017, Maclean’s Opposition stands behind former MP accusing Health Canada of gutting drug safety law, Amy Minsky, August 18, 2017, Global News Former MP… Continue reading Recent ADR News

“[Genetic testing is] going to make people healthier, it’s going to make drugs safer and it’s going to save money in the end.”

Mark Kunzli, pharmacist and UBC pharmacogenomics researcher

Each year, up to 22,000 Canadians die from an Adverse Drug Reaction.